Background There is increasing use of therapeutic aerosols in patients undergoing mechanical ventilation. Few studies have measured aerosol delivery to the lungs under these conditions with adequate experimental methods. Hence this study was performed to measure pulmonary aerosol deposition and to determine the reproducibility of the method of measurement during mechanical ventilation. Methods Nine male patients were studied during mechanical ventilation after open heart surgery and two experiments were performed in each to determine the reproducibility of the method. A solution of technetium-99m labelled human serum albumin (Q""Tc HSA (50 ,ug); activity in experiment 1, 74 MBq; in experiment 2, 185 MBq) in 3 ml saline was administered with a Siemens Servo 945 nebuliser system (high setting) and a System 22 Acorn nebuliser unit. Pulmonary deposition was quantified by means of a gamma camera and corrections derived from lung phantom studies. Results Pulmonary aerosol deposition was completed in 22 (SD 4) minutes. Total pulmonary deposition (% nebuliser dose (SD)) was 2*2 (0.8)% with 1*5% and 0 7% depositing in the right and left lungs respectively; 0.90%o of the nebuliser activity was detected in the endotracheal tube or trachea and 51% was retained within the nebuliser unit. Considerable variability between subjects was found for total deposition (coefficient of variation (CV) 46%), but within subject reproducibility was good (CV 15%). Conclusions Administration of aerosol in this way is inefficient and further research is needed to find more effective alternatives in patients who require mechanical respiratory support. This method of measurement seems suitable for the assessment of new methods of aerosol delivery in these patients. (Thorax 1993;48:154-159) 
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In vitro studies and animal studies performed during mechanical ventilation5 6 have suggested that considerable deposition of aerosol occurs in the endotracheal tube with little of the drug dose reaching the lungs. The limited human data available suggest that only 1-2%-2-9% of the nebuliser dose reaches the lungs.'-7 These studies have used 99mTc diethylenetriaminepenta-acetate and 99mTc sulphur colloid; however, both these tracers seemed unsuitable for measuring pulmonary aerosol deposition.8 '0 Colloidal 99mTc human serum albumin (99mTc HSA) appeared more appropriate9-12 and the validity and reproducibility of measurements made with this marker during spontaneous respiration have been reported. '3 The aims of our study were to apply the 99mTc HSA marker technique to the measurement of pulmonary deposition of aerosol during mechanical ventilation in a group of patients with apparently healthy lungs after open heart surgery. The study had two main arms: firstly, to measure the deposition efficiency of an inspiratory phase activated jet nebuliser system with equipment that has not been: studied before though it is commonly used in intensive care units; secondly, to determine the immediate reproducibility of these measurements of aerosol deposition.
Methods
The study was approved by the ethics committee of West Lambeth Health District. Patients about to undergo elective open heart surgery were invited to participate and all those taking part gave informed written consent. Those patients with pre-existing respiratory symptoms or disease were excluded as the intention of the study was n at that f ventilay medical ;tudy and ned writand were go 900C control :heal tube performed on each patient. The first study (experiment 1) was performed with a nebuliser solution of 74 MBq 99mTc HSA (50 ,ug) in 3 ml saline. During the 30 minute period of administration of aerosol the appearance of 99mTc HSA in the lungs was monitored continuously (anterior projection) with a portable gamma camera (small field of view with diverging collimator) in 15 second counting frames. After aerosol administration 300 secray film. ond static scans were taken of the lungs (pose basis of terior and anterior projections) and from and were these the geometric mean intrapulmonary rial blood activity was calculated.'3 The posterior view I patients was obtained by scanning the lungs from underneath through the bed. Activity in the vas mea-nebuliser was measured with the gamma technique camera before and after nebulisation. g subjects Experiment 2 was performed immediately 15 Before after completion of experiment 1. Identical 33 ('33Xe) nebulisation equipment, ventilator settings, to define and experimental methods were used except [his was that on this occasion the nebuliser solution MBq) of contained 185 MBq 99mTc HSA activity. er mount Activity detected in the chest after experiment the endo-1 was subtracted from that measured after fore infla-experiment 2. opped for Absolute pulmonary deposition of the nebvere filled ulised aerosol, expressed as a percentage of age was the initial nebuliser dose, was estimated by a ima cam-modification of the lung phantom method tion was described by Newman et al. ' Table   Table 2 Radioaerosol distribution (n = 9) Deposition (%) CV (%) 1 shows their clinical details, including their preoperative lung function and ventilation conditions after operation. Three were smokers and six were ex-smokers. All had undergone coronary artery bypass graft surgery and were intubated with 8 or 9 mm cuffed endotracheal tubes. Figure 2 shows the dynamic aerosol deposition. For each experiment deposition was completed within the 30 minute period of study and the mean time for completion (time to plateau) was 23 minutes for experiment 1 and 24 minutes for experiment 2. Figure 3 presents examples of representative I"Xe ventilation and 99mTc HSA deposition scans. These show poor ventilation and deposition of aerosol in the left lung. This pattern was found in six of the patients; in one patient ventilation and deposition in the right lung was poor. Substantial deposition of aerosol was found around the lower part of the endotracheal tube.
Quantification of aerosol deposition showed that only 3-2% of the initial nebuliser dose reached the patient's respiratory tract. Of this, 1% was deposited in the endotracheal tube or trachea and only 2-2% reached the lungs (table 2) . Most of the nebuliser solution was retained within the nebuliser unit or was deposited in the nebuliser connection or catheter mount; 11-5% of the aerosol was deposited in the exhalation port filter; and 32% of the initial nebuliser activity was not accounted for, presumably because of deposition within the ventilator circuit. It was not possible to verify this directly because of the size of the circuit-several metres of semirigid tubing, two traps, and a large heated water bath-and because of the difficulty in making a reliable correction for the geometric distribution of counts.
Deposition of aerosol in various lung regions (expressed as corrected counts) and deposition ratios of peripheral:central lung and upper:lower lung (each corrected for regional lung ventilation from similar ratios collected from the '33Xe scan) indicated preferential deposition of aerosol in the central and upper lung regions (table 2) . Table 2 shows the repeatability of the (fig 4, lower  panel) . This showed a mean bias of 1-05 with I estimated deposition to be 2-8% from a 99mTc diethylenetriaminepenta-acetate marker. This marker may also underestimate lung deposition as it is rapidly removed from the lungs into the bloodstream. Furthermore some of the activity may have been in the pulmonary blood pool rather than in the air passages, introducing further error. In neither study were both anteroposterior and posteroanterior scans taken for the determination of geometric mean counts. This will lead to further inaccuracy if the front to back distribution of pulmonary activity is uneven.
The marker used in our experiments is more suitable for deposition work because it is not removed from the lungs by passage into the bloodstream and remains at its site of deposition for several hours before removal by mucociliary clearance. This process is slow and no corrections are required to take it into account. The behaviour of the tracer in the aerosol seems to mimic that of therapeutic drugs9-1 and its addition does not alter particle sizes significantly."" 1 We have used the geometric mean count to obtain estimates of pulmonary deposition. Our lung phantom, used to correct deposition data for tissue attenuation and geometric errors, was shown in preliminary studies to be associated with attenuation similar to that in our patients and this phantom method of correction estimates actual intrapulmonary activity to within 6%. 21 With these methods we have confirmed that aerosol delivery is poor during mechanical ventilation. The lung deposition of 2-2% found here is much less than the 5% deposition measured with both the same methods and nebuliser during spontaneous breathing, but is consistent with the delivery of 4%-5% through an endotracheal tube in in vitro models.22 2' Deposition varied widely between patients, as has been found in subjects breathing normally,'3 but immediate reproducibility within the same patient was good. The distribution of deposition within the lungs was similar to that previously found in supine subjects breathing spontaneously; increased aerosol was deposited in the upper lungs. ' Several ways of improving aerosol delivery during mechanical ventilation have been suggested. These include use of nebulisers producing submicronic particles, which are less likely to deposit on the tubing56; increasing the volume of nebuliser solution and thus the drug output of the nebuliserl" 23; changing the ventilator settings to increase the inspiratory23 or pause times; altering the position of the nebuliser in the ventilator circuit2326 or the length of tubing between nebuliser and patient25; or making use of large capacity ultrasonic nebulisers23 or pressurised metered dose inhalers, with27 or without' spacer attachments. None of these techniques has yet been compared in vivo by adequate experimental methods. The method described here seems suitable for such studies because it uses an adequate tracer and method of estimating intrapulmonary activity and because paired measurements can be made in the same patient within a short time with acceptable repeatability. This is important as it allows patients to be studied with different nebuliser arrangements before their clinical state changes. In view of the poor aerosol delivery found with current methods of aerosol administration under these conditions, such studies are urgently required.
